Markets:

Overview

News

Currencies

International

Treasuries

Tivic Health Systems, Inc. - Common stock (NQ:TIVC)

1.400 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Tivic Health Systems, Inc. - Common stock

< Previous 1 2 3 4 5 Next >

Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod

March 31, 2026

Via ACCESS Newswire

Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference

March 27, 2026

Via ACCESS Newswire

Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome

March 26, 2026

Via ACCESS Newswire

Tivic Reports Full Year 2025 Results

March 25, 2026

Via ACCESS Newswire

Tivic Health CEO Letter to Shareholders

March 24, 2026

Via ACCESS Newswire

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

March 20, 2026

Via ACCESS Newswire

Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma

March 04, 2026

Via ACCESS Newswire

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

February 18, 2026

Via ACCESS Newswire

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

January 23, 2026

Via ACCESS Newswire

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

January 20, 2026

Via ACCESS Newswire

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

January 12, 2026

Via ACCESS Newswire

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

January 08, 2026

Via ACCESS Newswire

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

December 11, 2025

Via ACCESS Newswire

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

November 18, 2025

Via ACCESS Newswire

Tivic Reports Third Quarter 2025 Financial Results

November 14, 2025

Via ACCESS Newswire

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

November 13, 2025

Via ACCESS Newswire

Tivic Expands Intellectual Property Portfolio

November 10, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

November 06, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

October 22, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference

September 22, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

September 10, 2025

From Tivic Health® Systems, Inc.

Via Business Wire

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

August 20, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

August 15, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Reports Second Quarter 2025 Financial Results

August 14, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

August 07, 2025

From Tivic Health® Systems, Inc.

Via Business Wire

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

July 08, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

June 25, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health Announces 2025 Annual Meeting of Stockholders

June 24, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Life Sciences Investor Forum: Now Available for Online Viewing

June 13, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Investor Forum Agenda Announced for June 11th-12th

June 10, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.